Related Experiment Videos

Selective sigma ligands block stimulant effects of cocaine

M Menkel¹, P Terry, M Pontecorvo

¹Drug Development Group, NIDA Addiction Research Center, Baltimore, Maryland 21224.

European Journal of Pharmacology

|August 29, 1991

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force.

The journal of prevention of Alzheimer's disease·2022

The α2,3-selective potentiators of GABAA receptors, KRM-II-81 and MP-III-80, produce anxiolytic-like effects and block chemotherapy-induced hyperalgesia in mice without tolerance development.

Pharmacology, biochemistry, and behavior·2020

R-(-)-ketamine modifies behavioral effects of morphine predicting efficacy as a novel therapy for opioid use disorder1.

Pharmacology, biochemistry, and behavior·2020

The α2,3-selective potentiator of GABAA receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats.

Pharmacology, biochemistry, and behavior·2019

Bioisosteres of ethyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo [1,5-a][1,4]diazepine-3-carboxylate (HZ-166) as novel alpha 2,3 selective potentiators of GABAA receptors: Improved bioavailability enhances anticonvulsant efficacy.

Neuropharmacology·2018

An antidepressant-related pharmacological signature for positive allosteric modulators of α2/3-containing GABAA receptors.

Pharmacology, biochemistry, and behavior·2018

See all related articles